![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter
Early postoperative intraperitoneal chemotherapy for gastric cancer
Gastric cancer remains a major cause of cancer death, despite an unexplained decrease in its incidence in the United States during the past 50 years. Despite recent advances in diagnostic methods, many cases o...
-
Chapter and Conference Paper
Tumor Markers (AFP, CEA, CA19-9, CA125) for Detecting Recurrence of Gastric Cancer
The presence of serum markers was evaluated in 58 patients with recurrent gastric cancer. Of 32 patients with peritoneal recurrence, the percentage of patients whose serum samples were positive for AFP, CEA, C...
-
Chapter
Intraperitoneal 5-fluorouracil and mitomycin C as adjuvants to resectable gastric cancer: A status report
Despite recent advances in diagnostic methods, many patients with gastric cancer are seen with stage II or more advanced disease. Although there has been some improvement in survival rates due to meticulous at...
-
Article
Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer
Since a weekly administration of paclitaxel has demonstrated a sustained efficacy and more favorable toxicity profile than a 3-weekly administration for various solid tumors, the present study was conducted to...
-
Article
TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin
The present study analyzed the polymorphisms of apoptosis-related genes and their impact on the response to chemotherapy and survival of patients with advanced gastric cancer.
-
Article
General perioperative management of gastric cancer patients at high-volume centers
Gastric cancer is very common in Korea and Japan, where many hospitals annually perform high numbers of gastrectomies for gastric cancer. The aim of this study was to compare the general management of gastric ...
-
Article
Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancer
Purpose The feasibility of a 3-week combination of S-1 and cisplatin as an adjuvant chemotherapy for patients with curatively resected gastric cancer was investigated. Experimental design
-
Article
Phosphorylated AMP-activated protein kinase expression associated with prognosis for patients with gastric cancer treated with cisplatin-based adjuvant chemotherapy
The present study analyzed the expression of phosphorylated AMP-activated protein kinase (pAMPK), Fyn kinase, and pyruvate dehydrogenase kinase-1 (PDK-1) and their impact on the survival of patients with resec...
-
Article
Open AccessIntratumoural PD-L1 expression is associated with worse survival of patients with Epstein–Barr virus-associated gastric cancer
This study investigated the clinical relevance and prognostic impact of the overall expression of programmed cell death protein ligand-1 (PD-L1) and programmed cell death protein ligand-2 (PD-L2), in patients ...